We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App





Randox Showcases Latest Developments for Diagnostics Market at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 06 Feb 2023
Print article
Image: Acusera 24•7 is a live, cloud based interlaboratory data management and peer group reporting software (Photo courtesy of Randox)
Image: Acusera 24•7 is a live, cloud based interlaboratory data management and peer group reporting software (Photo courtesy of Randox)

Randox Laboratories (Crumlin, UK) is showcasing its latest developments for the diagnostics market at Medlab Middle East 2023 taking place live, in-person from 6-9 February 2023, in Dubai.

At the 22nd edition of Medlab Middle East Congress, Randox is highlighting its RX series of clinical chemistry analyzers for high quality semi-automated and fully automated testing, including RX daytona+, RX Monaco, RX imola, RX Modena, and RX misano. The RX series combines robust hardware and intuitive software with the world leading RX series test menu, including routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing. Renowned for quality and reliability, the RX series has one of the most extensive dedicated clinical chemistry test menus on the market guaranteeing real cost savings through consolidation of routine and specialized tests onto a single platform. This extensive dedicated test menu of high quality reagents guarantees excellence in patient care ensuring unrivalled precision and accuracy reducing costly test re-runs or misdiagnosis and offering complete confidence in results. With placements in over 120 countries worldwide, the RX series continues to revolutionize a variety of laboratory types including clinical laboratories and hospital laboratories.

At this year’s Medlab Middle East, Randox is also showcasing the Vivalytic platform, a universal, fully automated all in one solution for molecular diagnostics, the VeraSTAT portable point of care reader based on cathodic electro chemiluminescence technology, and the Discovery molecular & immunoassay diagnostic analyzer. Also on display at the show is the fully automated Evidence MultiSTAT immunoanalyser that enables on-site simultaneous detection of up to 44 analytes from a single sample of oral fluid, urine or blood.

In addition, Randox is presenting its extensive range of third party diagnostic reagents which produce accurate and precise results, alongside Acusera true third party quality controls that offer complete test menu consolidation for laboratory Internal Quality Control. Alongside, Randox is demonstrating Acusera 24.7, an Interlaboratory data management and peer group reporting package complementing the Acusera range of true third-party controls. Designed to help laboratories efficiently and effectively manage their daily QC activities, Acusera 24.7 offers several benefits to laboratories.

Related Links:
Randox Laboratories

Gold Member
Turnkey Packaging Solution
HLX
Unit-Dose Packaging solution
HLX
New
Dengue Virus Immunochromatographic Assay
STANDARD Q Dengue IgM/IgG Test
New
Respiratory Syncytial Virus Test
QuickVue RSV Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: A scanning electron microscope image of chiral gold nanoparticles developed for a new microfluidic chip (Matter, 2024; DOI: 10.1016/j.matt.2024.09.005)

Simple Blood Draw Helps Diagnose Lung Cancer 10 Times Faster

Once dismissed as cellular waste, exosomes—tiny vesicles released by cells containing proteins, DNA, or RNA fragments—have emerged as vital players in cell-to-cell communication over the past decade.... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.